Innovative Technologies To Accelerate Identification Of High-Quality Clones Webinar

Cell line development (CLD) often feels like a race against time. Finding the right clone that stably produces antibodies at high yields and meets the necessary critical quality attributes (CQAs) may feel like a struggle. The journey to identify high-quality clones is fraught with various challenges, including the need for repeated clone stability studies, multiple assessments of CQAs, and the efficient management and collection of data. These issues can significantly slow the pace of scientific progress, delay process optimization and prevent scale-up activities.

In this webinar, you will discover how to navigate these hurdles more effectively by leveraging innovative technologies from the Life Sciences Companies of Danaher. We aim to underscore the importance of deploying strategically selected, fit-for-purpose technologies. These are crucial for overcoming the challenges of finding the most stable, high-yield clones and assessing CQAs early in the process, thereby accelerating your CLD timelines.

During this webinar, you’ll learn:

• How to overcome bottlenecks in CHO cell line development with an introduction to the New Cydem VT Automated Clone Screening System.
• How to accelerate charge variant identification during early cell line development to guide decisions throughout the pipeline.
• How laboratory execution in a data-driven environment can help elevate data from the unit operation to the enterprise.